A new report shows the equivalence of YSI’s 2300 STAT Plus Glucose and Lactate Analyser and their new 2900D Biochemistry Analyser for reference measurements and system calibration of blood glucose monitoring systems.
YSI, a Xylem brand, have an established reputation in laboratory and field analytical instrumentation. Their YSI 2300 STAT Plus Glucose and Lactate Analyser (YSI 2300) was a Class II in-vitro diagnostics (IVD) medical device that became widely accepted by manufacturers as a method for reference measurements and system calibration of blood glucose monitoring systems.
YSI’s next-generation 2900D biochemistry analyser is a laboratory instrument that employs the same biosensor technology as the YSI 2300, but is a non-IVD analyser. The YSI 2900 is intended for use in research, biotechnology and food-processing applications, but it is not specifically designed for clinical diagnostics and sports physiology applications, although it has been increasingly adopted as a reference standard by blood glucose monitoring system manufacturers.
A paper now available reports on a study that compares the YSI 2900 and YSI 2300 in order to evaluate their precision and accuracy for human whole blood and plasma analysis. Non-pooled samples from six lots of human blood from a local blood bank were used for the study to assess instrument validity and reliability. Two analysers of each YSI model were employed with 288 human whole blood and 288 plasma samples, across a range of values, were analysed.
Data collected on the YSI 2900 analysers indicate that the 2900 provided precise and accurate whole blood and plasma glucose readings across a wide range of blood glucose concentrations. Based on the results of this study, it was concluded that the YSI 2900 demonstrated analytical comparability to that of the YSI 2300.
The full report can be read as a PDF, available for download on this website. Please click on the link below for more details.
